User profiles for Sandeep Gurram

Sandeep Gurram

Verified email at nih.gov
Cited by 1130

[HTML][HTML] MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis

…, PT Gomella, J Bloom, S Gurram… - … England Journal of …, 2020 - Mass Medical Soc
Background The use of 12-core systematic prostate biopsy is associated with diagnostic
inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer. …

Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase–deficient renal cancer

…, N Maio, M Lang, CJ Ricketts, CD Vocke, S Gurram… - Science …, 2021 - science.org
Understanding the mechanisms of the Warburg shift to aerobic glycolysis is critical to
defining the metabolic basis of cancer. Hereditary leiomyomatosis and renal cell carcinoma (…

Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) or sporadic papillary …

R Srinivasan, S Gurram, M Al Harthy, EA Singer… - 2020 - ascopubs.org
5004 Background: HLRCC is a familial cancer syndrome associated with a type 2 papillary
RCC (pRCC) variant. HLRCC is caused by germline mutations in the gene for the Krebs …

Prospective evaluation of PI-RADS version 2.1 for prostate cancer detection and investigation of multiparametric MRI–derived markers

…, C Garcia, LA Hazen, A Toubaji, MJ Merino, S Gurram… - Radiology, 2023 - pubs.rsna.org
Background Data regarding the prospective performance of Prostate Imaging Reporting and
Data System (PI-RADS) version 2.1 alone and in combination with quantitative MRI features …

Why does magnetic resonance imaging-targeted biopsy miss clinically significant cancer?

…, N Yerram, S Mehralivand, S Gurram… - The Journal of …, 2022 - auajournals.org
Purpose: Multiple studies demonstrate magnetic resonance imaging (MRI)-targeted biopsy
detects more clinically significant cancer than systematic biopsy; however, some clinically …

Using Prostate Imaging-Reporting and Data System (PI-RADS) scores to select an optimal prostate biopsy method: a secondary analysis of the Trio study

…, NK Yerram, LP O'Connor, AZ Wang, S Gurram… - European urology …, 2022 - Elsevier
Background While magnetic resonance imaging (MRI)-targeted biopsy (TBx) results in better
prostate cancer (PCa) detection relative to systematic biopsy (SBx), the combination of both …

[HTML][HTML] Social media and research publication activity during early stages of the COVID-19 pandemic: longitudinal trend analysis

…, S Bhattacharya, SA Schueler, S Gurram… - Journal of Medical …, 2021 - jmir.org
Background The COVID-19 pandemic has highlighted the importance of rapid dissemination
of scientific and medical discoveries. Current platforms available for the distribution of …

Comparison of MRI-based staging and pathologic staging for predicting biochemical recurrence of prostate cancer after radical prostatectomy

…, HL Parnes, YM Law, S Gurram… - American Journal of …, 2023 - Am Roentgen Ray Soc
BACKGROUND. Currently most clinical models for predicting biochemical recurrence (BCR)
of prostate cancer (PCa) after radical prostatectomy (RP) incorporate staging information …

Cabozantinib plus nivolumab phase I expansion study in patients with metastatic urothelial carcinoma refractory to immune checkpoint inhibitor therapy

…, KS Chan, MJ Lee, S Lee, Y Yu, S Gurram… - Clinical Cancer …, 2022 - AACR
Purpose: This study investigated the efficacy and tolerability of cabozantinib plus nivolumab
(CaboNivo) in patients with metastatic urothelial carcinoma (mUC) that progressed on …

PI-RADS Version 2.0 Versus Version 2.1: comparison of prostate cancer Gleason grade upgrade and downgrade rates from MRI-targeted biopsy to radical …

…, YM Law, BJ Wood, S Gurram… - American Journal of …, 2024 - Am Roentgen Ray Soc
BACKGROUND. Precise risk stratification through MRI/ultrasound (US) fusion-guided targeted
biopsy (TBx) can guide optimal prostate cancer (PCa) management. OBJECTIVE. The …